期刊文献+

CCL15在不同转移潜能人肝癌细胞株中的功能分析

Biological function explore of protein CCL15 in HCC cell lines
原文传递
导出
摘要 目的解析CeL15的生物学功能,验证其是否在肝癌侵袭、转移和复发中发挥作用。方法用RT-PCR、Westemblot分别检测CCL15在不同转移潜能人肝癌细胞株中的基因和蛋白表达水平并进行比较。用CCL15特异性的小干扰RNA质粒转染高转移潜能人肝癌细胞株HCCML3,得到CeL15低表达的细胞株HccML3-SiCCL15,通过划痕实验和Matrigel体外侵袭实验观察CeL15表达降低后对HCCML3细胞生物学行为的影响。数据用均数±标准差伍±s)表示,用SPSS11.0统计软件包进行t检验。结果CeL15在有转移潜能人肝癌细胞株HCCML3和MHCC97-L中高表达。划痕实验结果显示,HCCML3组和HCCML3siCCLl5组划痕两侧边缘之间的距离分别是(0.35士0.02)mm和(0.82±0.03)mm(t=15.67,P〈0.05)。Matrigel侵袭实验结果显示,HCCML3组和HCCML3-siCCLl5组平均每视野侵袭细胞分别为(657.9±22.9)个和(148.4±10.2)个(t=19.34,P〈0.05)。HccML3-SiccL15组细胞内基质金属蛋白酶(MMP-9表达水平明显低于HCCML3组。结论降低CCLl5表达后HCCML3细胞迁移和侵袭能力均明显降低,细胞内MMP-9表达水平降低。提示CCL15通过增强肝癌细胞的运动侵袭能力和上调MMP-9的分泌参与肝癌细胞的侵袭、转移过程。 Objective To explain biological function of protein CCL15 in HCC cell lines. Methods The different expression level of CCL15 among HCC cell lines was validated by RT-PCR and Western blot. The expression recombinant plasmid of siRNA-CCL15 was constructed successfully and transfected into high metastasic cell lines HCCML3 to observe the alteration of biological function of HCCML3. Results The overexpression of CCL15 in high metastasic HCC cell lines was confirmed by validation tests. After transfected with siRNA-CCL15, the average amounts of invaded cells in cell invasion assay were 657.9 (HCCML3) and 148.4(HCCML3-siCCL15) (t= 19.34, P〈0.05). And in the scratch assay, the migrating distance were (0.35 ± 0.02) mm (HCCML3) and (0.82 ± 0.03)mm (HCCML3-siCCL15) (t= 15.67, P〈 0.05). The expression of MMP-9 in HCCML3 was higher than HCCML3-siCCL15 through Western blot. Conclusion Some biological properties (migration, invasion, MMP-9) of HCCML3 transfected with siRNACCL15 were decreased. The results suggest CCL15 might play an important role in HCC cell invasion and metastasis through two paths of MMPs regulation and invasion potential strengthening.
作者 李悦国 张鹏
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2012年第5期372-376,共5页 Chinese Journal of Hepatology
基金 国家自然科学基金(81101754) 国家高技术研究发展计划(8635计划,2011AA02A111)
关键词 肝细胞 肿瘤转移 肿瘤侵润 CCL15 Carcinoma, hepatocellular Neoplasm metastasis Neoplasm invasiveness CCL15
  • 相关文献

参考文献9

  • 1李悦国,耿鑫,朱国平,张维铭.肝癌病人血清蛋白质指纹图谱检测及其临床意义[J].中华肝胆外科杂志,2007,13(10):663-666. 被引量:5
  • 2李悦国,张宁.趋化因子CCL15在肝细胞肝癌组织中的表达及其临床意义[J].中国肿瘤临床,2011,38(2):87-88. 被引量:4
  • 3Dubinett SM, Lee JM, Shanna S, et al. Chemokines: can effector cells be redirected to the site of the tumor? Cancer J, 2010, 16: 325- 335.
  • 4Miiller-Hiibenthal B, Azemar M, Lorenzen D, et al. Tumour biology: tumour-associated inflammation versus antitumor immunity. Anticancer Res, 2009, 29: 4795-4805.
  • 5Gao LB, Pan XM, Jia J, et al. IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. Eur J Cancer, 2010, 46: 1333-1343.
  • 6Takahashi M, Galligan C, Tessarollo L, et al. Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J Immunol, 2009, 183: 3463-3471.
  • 7Cheng J, Zhang D, Kim K, et al. Mipl, an MEKK2-interacting protein, controls MEKK2 dimerization and activation. Mol Cell Biol, 2005, 25" 5955-5964.
  • 8Sung H J, Kim YS, Kang H, et al. Human LZIP induces monocyte CC chemokine receptor 2 expression leading to enhancement of monocyte chemoattractant protein I/CCL2-induced cell migration. Exp Mol Med, 2008, 40: 332-338.
  • 9Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from to tumor escape. Nat Immunol, 2002, 3: 991-998.

二级参考文献21

  • 1李悦国,张维铭.蛋白质组学在肝癌及其相关疾病研究中的应用[J].中国肿瘤临床,2005,32(16):957-960. 被引量:4
  • 2Ou DL,Chen CL,Lin SB,et al.Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy[J].J Pathol,2006,210(3):363-373.
  • 3Mori K,Chano T,Yamamoto K,et al.Expression of macrophage inflammatory protein-lalpha in Schwann cell tumors[J].Neuropa-thology,2004,24(2):131-135.
  • 4Vande Broek I,Leleu X,Schots R,et al.Clinical significance of chemokine receptor (CCR1,CCR2 and CXCR4) expression in human myeloma cells:the association with disease activity and surviv-al[J].Haematologica,2006,91(2):200-206.
  • 5Sung HJ,Kim YS,Kang H,et al.Human LZIP induces monocyte CC chemokine receptor 2 expression leading to enhancement of monocyte chemoattractant protein 1/CCL2-induced cell migration[J].Exp Mol Med,2008,40(3):332-338.
  • 6Hwang J,Kim CW,Son KN,et al.Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo[J] ,FEBS Lett,2004,570 (1-3):47-51.
  • 7Scotton C,Milliken D,Wilson J,et al.Aanlysis of CC chemokine and chemokine receptor expression in solid ovarian tumours[J].Br J Cancer,2001,85(6):891-897.
  • 8Reckamp KL,Gardner BK,Figlin RA,et al.Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin[J].J Thorac Oncol,2008,3(2):117-124.
  • 9Ko J,Kim IS,Jang SW,et al.Leukotactin-1/CCL15-induced che-motaxis signaling through CCR1 in HOS cells[J].FEBS Lett,2002,515(1-3):159-164.
  • 10Lee JS,Kim IS.Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation[J].Mol Biol Rep,2010,37(5):2149-2156.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部